Celldex Therapeutics, Inc.
CLDX
$32.45
$0.451.41%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -12.94% | -11.08% | -7.47% | -6.38% | -7.17% |
| Total Receivables | -88.59% | 2,138.89% | 0.00% | -91.54% | 52.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -46.48% | -33.05% | 16.96% | -7.34% | -8.39% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -14.11% | -11.53% | -6.80% | -6.54% | -7.15% |
|
|
|||||
| Total Current Assets | -14.11% | -11.53% | -6.80% | -6.54% | -7.15% |
| Net Property, Plant & Equipment | 21.07% | 2.98% | 0.44% | -7.42% | -1.56% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 15.54% | 42.65% | 0.69% | -10.65% | 6.79% |
| Total Assets | -12.30% | -10.09% | -6.35% | -6.36% | -6.67% |
|
|
|||||
| Total Accounts Payable | 777.88% | -72.35% | 105.84% | -39.21% | 4.44% |
| Total Accrued Expenses | -18.31% | 18.42% | 39.72% | 11.66% | -24.78% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -5.61% | -0.06% | 1.11% | 2.47% | 3.24% |
| Total Finance Division Other Current Liabilities | 0.00% | 32.26% | 0.00% | -43.74% | 75.48% |
| Total Other Current Liabilities | 0.00% | 32.26% | 0.00% | -43.74% | 75.48% |
| Total Current Liabilities | 0.94% | 9.74% | 40.96% | 2.95% | -18.94% |
|
|
|||||
| Total Current Liabilities | 0.94% | 9.74% | 40.96% | 2.95% | -18.94% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -43.49% | -26.59% | -28.56% | -22.50% | -18.30% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -23.00% | 58.99% | 0.00% | 0.00% | -26.78% |
| Total Liabilities | -1.42% | 11.47% | 35.34% | 1.40% | -19.51% |
|
|
|||||
| Common Stock & APIC | 0.38% | 0.44% | 0.41% | 0.40% | 0.41% |
| Retained Earnings | -4.34% | -4.69% | -4.03% | -3.52% | -3.46% |
| Treasury Stock & Other | -30.45% | -3.69% | 12.76% | -6.42% | 7.66% |
| Total Common Equity | -13.46% | -11.90% | -8.70% | -6.77% | -5.89% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -13.46% | -11.90% | -8.70% | -6.77% | -5.89% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -13.46% | -11.90% | -8.70% | -6.77% | -5.89% |
|
|
|||||